Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic

Elgazzar et al., Research Square, doi:10.21203/rs.3.rs-100956/v2 (Preprint)

Elgazzar et al., Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic, Research Square, doi:10.21203/rs.3.rs-100956/v2 (Preprint)

Nov 2020 Source PDF

Twitter
Facebook

All Studies Meta

This study was withdrawn.

Important missing comments or errors? Let us know.

Elgazzar et al., 13 Nov 2020, preprint, 6 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Ivermectin All

Abstract: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic Article Keywords: Posted Date: July 14th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-100956/v4 License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License EDITORIAL NOTE: Research Square withdrew this preprint on 14 July, 2021 due to an expression of concern communicated directly to our staff. These concerns are now under formal investigation. (note updated 19 July, 2021) Page 1/2 Abstract Research Square has withdrawn this preprint. Full Text Research Square has withdrawn this preprint. Page 2/2

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit